Search research articles
Contact Us
Filters
Showing results (61-70 of 120) with videos related to
Page
of 12
Sort By:
Leukemia & Lymphoma
|
January 29, 2021
A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma
Sahar Khan, Richard LeBlanc, Martin Gyger, et al.
Neurosurgery
|
August 29, 2003
Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas
Yevgeniy E Kuznetsov, Zografos Caramanos, Samson B Antel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 17, 2008
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis
Valerie Panet-Raymond, Luis Souhami, David Roberge, et al.
Cancer Research
|
April 4, 2002
Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes
Donna L Senger, Christopher Tudan, Marie-Christine Guiot, et al.
Blood
|
September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo
Boris Lin, Laurence Catley, Richard LeBlanc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 21, 2012
Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma
Andreas Holbro, Imran Ahmad, Sandra Cohen, et al.
Blood
|
August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells
Dharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Blood
|
September 27, 2003
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway
Richard LeBlanc, Teru Hideshima, Laurence P Catley, et al.
Experimental Hematology
|
July 24, 2002
beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells
Deepak Gupta, Klaus Podar, Yu Tzu Tai, et al.
Clinical Transplantation
|
September 27, 2020
Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only
Richard LeBlanc, Jean-Sébastien Claveau, Imran Ahmad, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 120) with videos related to
Sort By:
Page
of 12
Leukemia & Lymphoma
|
January 29, 2021
A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma
Sahar Khan, Richard LeBlanc, Martin Gyger, et al.
Neurosurgery
|
August 29, 2003
Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas
Yevgeniy E Kuznetsov, Zografos Caramanos, Samson B Antel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 17, 2008
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis
Valerie Panet-Raymond, Luis Souhami, David Roberge, et al.
Cancer Research
|
April 4, 2002
Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes
Donna L Senger, Christopher Tudan, Marie-Christine Guiot, et al.
Blood
|
September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo
Boris Lin, Laurence Catley, Richard LeBlanc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 21, 2012
Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma
Andreas Holbro, Imran Ahmad, Sandra Cohen, et al.
Blood
|
August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells
Dharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Blood
|
September 27, 2003
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway
Richard LeBlanc, Teru Hideshima, Laurence P Catley, et al.
Experimental Hematology
|
July 24, 2002
beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells
Deepak Gupta, Klaus Podar, Yu Tzu Tai, et al.
Clinical Transplantation
|
September 27, 2020
Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only
Richard LeBlanc, Jean-Sébastien Claveau, Imran Ahmad, et al.
Page
of 12